🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Seacross Pharma (Europe) Limited — Licensed Medicines

17 medicines held by Seacross Pharma (Europe) Limited on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 17 products held by Seacross Pharma (Europe) Limited
MedicineActive substanceLicence holderStatus
Apacross 5 mg/ml powder for dispersion for infusion
PA22766/015/001
Paclitaxel Seacross Pharma (Europe) Limited Not marketed
Azacitidine Seacross 25 mg/ml powder for suspension for injection
PA22766/005/001
Azacitidine Seacross Pharma (Europe) Limited Marketed
Cyclophosphamide Seacross 1000 mg powder for solution for injection/infusion
PA22766/013/003
Cyclophosphamide monohydrate Seacross Pharma (Europe) Limited Not marketed
Cyclophosphamide Seacross 200 mg powder for solution for injection/infusion
PA22766/013/001
Cyclophosphamide monohydrate Seacross Pharma (Europe) Limited Not marketed
Cyclophosphamide Seacross 2000 mg powder for solution for injection/infusion
PA22766/013/004
Cyclophosphamide monohydrate Seacross Pharma (Europe) Limited Not marketed
Cyclophosphamide Seacross 500 mg powder for solution for injection/infusion
PA22766/013/002
Cyclophosphamide monohydrate Seacross Pharma (Europe) Limited Not marketed
Docetaxel 20 mg/ml concentrate for solution for infusion
PA22766/001/001
Docetaxel (anhydrous) Seacross Pharma (Europe) Limited Marketed
Doxorubicin 2 mg/ml Concentrate for Solution for Infusion
PA22766/004/001
DOXORUBICIN HYDROCHLORIDE Seacross Pharma (Europe) Limited Not marketed
Epirubicin 2 mg/ml Solution for Injection
PA22766/003/001
Epirubicin hydrochloride Seacross Pharma (Europe) Limited Not marketed
Pemetrexed Seacross 100 mg powder for concentrate for solution for infusion
PA22766/002/001
Pemetrexed Seacross Pharma (Europe) Limited Not marketed
Pemetrexed Seacross 500 mg powder for concentrate for solution for infusion
PA22766/002/002
Pemetrexed Seacross Pharma (Europe) Limited Not marketed
Plerixafor Seacross 20 mg/ml solution for injection
PA22766/007/001
Plerixafor Seacross Pharma (Europe) Limited Marketed
Sodium Valproate Seacross 100 mg/ml solution for injection/infusion
PA22766/012/001
Sodium valproate Seacross Pharma (Europe) Limited Marketed
Teicoplanin Seacross 200 mg powder for solution for injection/infusion or oral solution
PA22766/011/001
Teicoplanin Seacross Pharma (Europe) Limited Not marketed
Teicoplanin Seacross 400 mg powder for solution for injection/infusion or oral solution
PA22766/011/002
Teicoplanin Seacross Pharma (Europe) Limited Not marketed
Voriconazole Seacross 200 mg powder for solution for infusion
PA22766/009/001
Voriconazole Seacross Pharma (Europe) Limited Marketed
Zoledronic acid Seacross 5 mg solution for infusion
PA22766/010/001
Zoledronic acid monohydrate Seacross Pharma (Europe) Limited Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.